Skip to content

EPSTEIN-BARR VIRUS LMP1 SIGNALING IN NASOPHARYNGEAL CARCINOMA ONCOGENESIS AND METASTSIS

EPSTEIN-BARR VIRUS LMP1 SIGNALING IN NASOPHARYNGEAL CARCINOMA ONCOGENESIS AND METASTSIS

Status
Recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-CCS-12002581
Enrollment
Unknown
Registered
2012-09-30
Start date
2012-02-14
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nasopharyngeal carcinoma

Interventions

None listed

Sponsors

Sun Yat-Sen University Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: pathologic verified NPC patients

Exclusion criteria

Exclusion criteria: Complicated with malignant tumor; perinatal period woman.

Countries

China

Contacts

Public ContactXiang Yanqun
xiangyq@sysucc.org.cn+86 18666096623

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026